STOCK TITAN
  1. Home
  2. News
  3. REGN

Regeneron Pharmaceuticals, Inc. - REGN STOCK NEWS

IMPACT
SENTIMENT
ABCL : Nasdaq REGN : Nasdaq
AbCellera Expands Multi-Target Antibody Discovery Collaboration with Regeneron
IMPACT
SENTIMENT
REGN : Nasdaq
Regeneron Provides Update on Planned Chief Financial Officer Transition
IMPACT
SENTIMENT
REGN : Nasdaq
Regeneron Announces Updates to Board of Directors
management
IMPACT
SENTIMENT
REGN : Nasdaq
Regeneron Announces Investor Conference Presentations
IMPACT
SENTIMENT
REGN : Nasdaq
Regeneron Announces Agreement with BARDA Supporting Development of Next-Generation Antibody Therapy for COVID-19 Prevention
covid-19
IMPACT
SENTIMENT
REGN : Nasdaq
EYLEA HD (aflibercept) Injection 8 mg Approved by FDA for Treatment of Wet Age-related Macular Degeneration (wAMD), Diabetic Macular Edema (DME) and Diabetic Retinopathy (DR)
IMPACT
SENTIMENT
REGN : Nasdaq
Veopoz™ (pozelimab-bbfg) Receives FDA Approval as the First Treatment for Children and Adults with CHAPLE Disease
fda approval
IMPACT
SENTIMENT
REGN : Nasdaq
Odronextamab Receives EMA Filing Acceptance for Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma
IMPACT
SENTIMENT
REGN : Nasdaq
Two-year PULSAR Trial Results for Aflibercept 8 mg Demonstrate Durable Vision Gains at Extended Dosing Intervals in Wet Age-related Macular Degeneration
IMPACT
SENTIMENT
REGN : Nasdaq
Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs
acquisition
Stock REGN logo
Regeneron Pharmaceuticals, Inc.

Nasdaq:REGN

REGN Rankings

#141 Ranked by Market Cap
#1795 Ranked by Stock Gains
N/A Ranked by Dividends

REGN Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Tarrytown

About REGN

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.